{
    "nct_id": "NCT06200259",
    "official_title": "Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement",
    "inclusion_criteria": "* Pathological proven diagnosis of prostatic adenocarcinoma\n* History and physical exam to establish clinical staging\n* Clinical stage T1-T2c (AJCC 7th edition)\n* Prostate specific antigen (PSA) < 20 ng/mL\n* Gleason Score â‰¤ 7\n* Eastern Cooperative Oncology Group (ECOG) Performance status 0-1\n* Patients must be 18 years of age or older\n* Willingness and ability to complete the International Prostate Symptom Score (IPSS) survey and Expanded Prostate Cancer Index Composite (EPIC) questionnaire\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior radiotherapy to the pelvic area\n* Prior prostate cancer therapy: cryotherapy or hyperthermia\n* Prior systemic therapy (chemotherapy) for prostate cancer\n* Regional lymph nodes (common iliac, external iliac, internal iliac, presacral) are a target of treatment\n* Active diverticulitis, ulcerative colitis, or Crohn's disease",
    "miscellaneous_criteria": ""
}